FIELD: medicine, peptides. SUBSTANCE: invention relates to development and use of the novel anxiolytic agent. Invention proposes to use heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro as an anxiolytic agent and the novel composition of anxiolytic agent containing indicated heptapeptide as an active substance in amount of 1.45-1.55 g/l, nipagine as a preserving agent in amount of 0.95-1.05 g/l and distilled water, the balance. Composition is used as nasal drops. EFFECT: high effectiveness in low doses, simplified using. 2 cl, 19 tbl, 14 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANXIOLYTIC AGENT | 1999 |
|
RU2175229C2 |
| ANTIANXIETY DRUGS AND PHARMACEUTICAL COMPOSITIONS WITH ANXIOLYTIC EFFECTS | 2014 |
|
RU2580311C1 |
| 1,4-BENZODIAZEPINE DERIVATIVES SHOWING SELECTIVE ANXIOLYTIC ACTIVITY | 1995 |
|
RU2133248C1 |
| 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES HAVING SELECTIVE ANXIOLYTIC ACTIVITY | 1994 |
|
RU2061686C1 |
| HEPTAPEPTIDE WITH ADAPTOGENIC AND ANXIOLYTIC ACTIVITY | 1999 |
|
RU2161500C1 |
| SUBSTITUTED 2-[2(3-OXOMORPHOLIN-4-YL)ETHYLTHIO]BENZIMIDAZOLES, WITH ANXIOLYTIC ACTIVITY | 2007 |
|
RU2373202C2 |
| MEDICATION POSSESSING ANXIOLYTIC ACTION | 2008 |
|
RU2394588C1 |
| AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
| AGENT POSSESSING ANXIOLYTIC, NOOTROPIC, ANTICONVULSANT, ANTIDEPRESSIVE, CEREBRO-PROTECTING ACTIVITY AND ABILITY TO NORMALISE TRANSFER PROCESSES IN BRAIN SYNAPSES | 2007 |
|
RU2335293C1 |
| DRUG SHOWING ANXIOLYTIC, ANTIALCOHOLIC AND CEREBROPROTECTIVE EFFECTS | 1999 |
|
RU2145855C1 |
